People with systemic sclerosis (SSc) that have borderline high pulmonary arterial pressure are at increased risk of…
Articles by Ana Pena, PhD
MannKind Corporation will start enrollment for a Phase 1 trial to test its treprostinil inhaled therapy for the treatment…
A new cardiac surgical procedure to treat mitral valve disease, which is minimally invasive, does not require open-heart…
The presence of systemic autoimmune rheumatic diseases (ARDs) — a comorbidity that can range from systemic sclerosis to…
Thirty percent of pulmonary arterial hypertension (PAH) patients experience depression or anxiety, according to a study that looked at patients’…
Tenax Therapeutics plans to advance its lead compound, levosimendan, into a Phase 2 clinical trial to treat pulmonary hypertension…